{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:36:11Z","timestamp":1789626971805,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1093\/jac\/dkx065","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T16:22:19Z","timestamp":1489422139000},"page":"1977-1980","source":"Crossref","is-referenced-by-count":83,"title":["Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans"],"prefix":"10.1093","volume":"72","author":[{"given":"Nathan P.","family":"Wiederhold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Birch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"key":"key\n\t\t\t\t20170616060947_dkx065-B1","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1128\/AAC.03211-14","article-title":"Susceptibility and diversity in the therapy-refractory genus Scedosporium","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/CMR.00039-07","article-title":"Infections caused by Scedosporium spp","volume":"21","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1470-9465.2004.00839.x","article-title":"Infections due to emerging and uncommon medically important fungal pathogens","volume":"10","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/13693780600752507","article-title":"Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist","volume":"44","year":"2006","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13225-014-0295-4","article-title":"Proposed nomenclature for Pseudallescheria, Scedosporium and related genera","volume":"67","year":"2014","journal-title":"Fungal Divers"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00005792-200209000-00001","article-title":"Pseudallescheria boydii (anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature","volume":"81","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/tid.12244","article-title":"Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients","volume":"16","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/426445","article-title":"Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B9","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1086\/509579","article-title":"Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006","volume":"43","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00001432-200312000-00015","article-title":"Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients","volume":"16","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B11","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/ajt.12691","article-title":"Epidemiology of invasive mold infections in lung transplant recipients","volume":"14","year":"2014","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1128\/AAC.49.3.945-951.2005","article-title":"In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B13","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1073\/pnas.1608304113","article-title":"F901318 represents a class of antifungal drug that inhibits dihydroorotate dehydrogenase","volume":"113","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B14"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B15"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B16","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1128\/JCM.43.10.4930-4942.2005","article-title":"Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species","volume":"43","year":"2005","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B17","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi\u2014Second Edition: Approved Standard M38-A2","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B18","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/597772","article-title":"Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report","volume":"48","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B19","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/jac\/dkt282","article-title":"In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170616060947_dkx065-B20"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/7\/1977\/17723356\/dkx065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T15:50:30Z","timestamp":1503589830000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkx065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,3,15]]},"published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx065","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]}}}